Speakers

Don Healey

Chief Technology Officer • Adicet Bio

Dr. Healey joined Adicet in October 2020 as Chief Technology Officer with nearly two decades of experience in cell therapy development and manufacturing. He joins Adicet most recently from KBI Biopharma Inc., a biopharmaceutical contract services organization, where he was responsible for establishing process development, manufacturing, quality control and facilities management for biopharmaceutical clients developing cellular therapies. Previously, he served as Chief Scientific Officer at Opexa Therapeutics, Inc., where he was responsible for all pre-clinical scientific development, closed-system process design and the scaling of Opexa’s autologous T-cell immunotherapy. Dr. Healey has also served as Director of Immunology at Argos Therapeutics Inc. and Group leader for Immunology at ML Laboratories, UK, (formerly Cobra Biotherapeutics). Dr. Healey received his Ph.D. from University of London, and holds a B.Sc. in Cellular Pathology from Bristol University.

Also Speaking

Dave Lennon

Chief Executive Officer • Satellite Bio

Anne Rowzee

Associate Director for Policy, Office of Tissues and Advanced Therapies • FDA

Stuart Gibb

Scientific Strategy Lead • Terumo Blood and Cell Technologies

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.